COMMUNIQUÉS West-GlobeNewswire

Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update
21/05/2024
Cash and cash equivalents at €11.0 million, short-term 2 deposits at €0.1million, and long-term deposit at €19.1 million 3 as of March 31, 2024, compared to €26.9 million, €0.01 million and €9.0 million as of December [...]
Inventiva publie ses informations financières du 1 ͤ ͬ trimestre 2024¹ et fait un point sur ses activités
21/05/2024
Au 31 mars 2024, trésorerie et équivalents de trésorerie à 11,0 millions d’euros, dépôt court terme 2 à 0,1 million d’euros et dépôt long terme à 19,1 millions d'euros 3 , contre 26,9 millions d’euros, 0,01 million d’ [...]
InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators
21/05/2024
JENA, Germany, May 21, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced data presented at the [...]
Smart for Life to Attend the 2024 NASC Annual Conference
21/05/2024
Management to Explore Strategic Partnerships and Acquisition Opportunities at Premier Animal Health Event MIAMI, May 21, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), [...]
ONWARD® Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication
21/05/2024
Nature Medicine published Up-LIFT pivotal trial results Company will discuss pivotal trial results during webcast this week with company leaders and study principal investigators and participants EINDHOVEN, the [...]
Legend Senior Living Earns Great Place to Work® Certification for Sixth Time
21/05/2024
WICHITA, Kan., May 21, 2024 (GLOBE NEWSWIRE) -- Great Place to Work Institute has honored Legend Senior Living® with certification as a Great Place to Work for the sixth time. The certification process considered more [...]
Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
21/05/2024
Leiden, the Netherlands, May 21, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces that at its Annual General Meeting of Shareholders (AGM) held today, all proposals were [...]
BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders
21/05/2024
Westport, CT, May 21, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or “Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal [...]
Genmab Completes Acquisition of ProfoundBio
21/05/2024
Company Announcement Genmab has completed acquisition of ProfoundBio for USD 1.8 billion in cash Acquisition gives Genmab worldwide rights to three candidates in clinical development, including rinatabart sesutecan ( [...]
Mobile-health Network Solutions Revenue Rises Approximately 120% in the First Six Months of Fiscal 2024
21/05/2024
SINGAPORE, May 21, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth provider, today announced that for the first six months of fiscal [...]
AssureCare Joins Forces with Health Plan Alliance to Enhance Healthcare Collaboration
21/05/2024
CINCINNATI, Ohio, May 21, 2024 (GLOBE NEWSWIRE) -- AssureCare, a leading healthcare technology and services company, proudly announces its support of the Health Plan Alliance, a prominent national organization dedicated [...]
Intrommune Therapeutics Presents Oral Mucosal Immunotherapy Updates at Leading Industry Events
21/05/2024
NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, Inc., a biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies, is pleased [...]
Merit Medical Launches basixSKY™ Inflation Device
21/05/2024
Versatile analog device offers fast inflation and ease of use, streamlining patient care SOUTH JORDAN, Utah, May 21, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare [...]
GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
21/05/2024
BRISBANE, CALIFORNIA, May 21, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ: GTBP) (the “Company”), today announced that it has entered into a definitive securities purchase agreements for the purchase and sale of [...]
Lyra Therapeutics Announces Cost-Cutting Measures to Preserve Capital
21/05/2024
WATERTOWN, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), today announced that it is advancing its goal to preserve capital by implementing a layoff of [...]
Molecure receives approval to initiate a Phase II clinical trial (KITE) for OATD-01 for the treatment of pulmonary sarcoidosis in selected countries of the European Union and Norway
21/05/2024
OATD-01 is a first-in-class chitotriosidase 1 (CHIT1) inhibitor with the potential to modify the course of disease in sarcoidosis and other interstitial lung diseases. Obtaining regulatory approvals in Denmark, France, [...]
Solera HALO™ Platform Expands Fertility and Women’s Healthcare Solution with Kindbody
21/05/2024
Kindbody fertility, family-building, and women’s healthcare services expand upon Solera’s existing women’s health offering – spanning the full lifecycle of women’s health needs PHOENIX, May 21, 2024 (GLOBE NEWSWIRE) -- [...]
Philips Foundation 2023 Annual Report: unlocking quality medical services for over 28 million people in underserved communities
21/05/2024
May 21, 2024 Progress towards Philips Foundation’s 2030 target of 100 million lives improved in underserved communities each year 17 new initiatives with strategic partners and 4 new investments in health tech [...]
NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
21/05/2024
CARMEL, Ind., May 21, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]

Pages